Palantir Reports Q1 2026 Earnings Beat with Revenue of $1.63 Billion

The company reported revenue of $1.63 billion, beating the expected $1.54 billion, and adjusted earnings per share of $0.33 against an estimate of $0.28. Multiple sources confirmed these figures, marking what the company described as its fastest revenue growth to date.

The results reflected robust performance in Palantir's core U.S. market, driven by demand for its software platforms. Adjusted EBITDA came in at $990.3 million, exceeding the forecast of $886.7 million. For the second quarter, Palantir projected revenue of $1.80 billion, above the consensus estimate of $1.68 billion.

Shares of Palantir, traded under the ticker PLTR, showed positive movement in after-hours trading following the release. The earnings beat arrived amid broader interest in artificial intelligence technologies, with the company noting explosive demand in its U.S. operations. Palantir also referenced concerns about subpar AI offerings in the industry.

“AI slop" — Palantir's description of inferior AI products, as reported in its earnings context (MarketWatch). No contradictions appeared across the sources, which aligned on the key financial metrics. The company's guidance suggests continued momentum into the next quarter.”

In a separate development, cannabis company Curaleaf is scheduled to report its first-quarter 2026 earnings after market close on May 5. Analysts anticipate a loss of $0.09 per share and revenue of $317.05 million for the period. This follows Palantir's report and highlights ongoing earnings activity in technology and emerging sectors.

Curaleaf trades over the counter under the symbol CURLF. The preview did not include additional details on guidance or operational updates.

Palantir's performance underscores strength in data analytics and AI-driven solutions for government and commercial clients. The company's U.S.-focused growth contrasted with global market dynamics, though specific international figures were not detailed in the reports.

Investors will watch how these results influence sector trends ahead of other tech earnings. The alignment of reported numbers across sources provides a clear picture of Palantir's quarter, with no disputed claims. Curaleaf's impending release could offer insights into the cannabis industry's trajectory, potentially affected by regulatory environments.

No further operational commentary was provided in the available sources beyond the financial highlights. The earnings reflect Palantir's positioning in a competitive landscape emphasizing AI capabilities.